Mid-term (up to 12 years) clinical and echocardiographic outcomes of percutaneous transvenous mitral commissurotomy in patients with rheumatic mitral stenosis

Mid-term (up to 12 years) clinical and echocardiographic outcomes of percutaneous transvenous mitral commissurotomy in patients with rheumatic mitral stenosis

Abstract Background Rheumatic heart disease (RHD) is still a concerning issue in developing countries. Among delayed RHD presentations, rheumatic mitral valve stenosis (MS) remains a prevalent finding. Percutaneous transvenous mitral commissurotomy (PTMC) is the intervention of choice for severe mit...

Full description

Bibliographic Details
Main Authors: Yahya Dadjo, Maryam Moshkani Farahani, Reza Nowshad, Mohsen Sadeghi Ghahrodi, Alireza Moaref, Javad Kojuri
Format: Article
Language:English
Published: BMC 2021-07-01
Series:BMC Cardiovascular Disorders
Subjects:
Mitral valve stenosis
Percutaneous transvenous mitral commissurotomy
Mid-term outcome
Adverse cardiac events
Restenosis
Online Access:https://doi.org/10.1186/s12872-021-02175-3

Internet

https://doi.org/10.1186/s12872-021-02175-3

Similar Items